Company profile
MEDLINE INC.
NASDAQ:MDLNMedical/Dental Instruments
Drug pipeline (1)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| READYPREP CHG | approved | — | 11 | approved |
Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.
Clinical trials (11)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02530541 | phase1_2 | completed | 2014-04-01 | 2014-07-01 | Medline Industries | Antimicrobial Efficacy of 2% CHG (Chlorhexidine Gluconate) |
| NCT03326726 | phase2 | completed | 2016-11-16 | 2016-11-18 | Medline Industries | Evaluation 2% Chlorhexidine Gluconate |
| NCT02224625 | phase3 | completed | 2014-08-01 | 2015-06-01 | Medline Industries | Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth |
| NCT02530554 | phase1_2 | completed | 2015-07-01 | 2015-08-01 | Medline Industries | Pilot Trial of Chlorhexidine Gluconate (CHG) Preoperative Skin Preparation |
| NCT02530528 | phase1_2 | completed | 2014-02-01 | 2014-04-01 | Medline Industries | Pilot Trial of Preoperative Chlorhexidine Gluconate (CHG) Skin Preparation |
FDA applications (1)
| Application | Approved | Type | Applicant | Products | ||||
|---|---|---|---|---|---|---|---|---|
| NDA 207964 | 2018-11-20 | NDA | MEDLINE INDUSTRIES INC | |||||
Loading… | ||||||||